Tryptic hydrolysis of hGH-RH(1-29)-NH2 analogues containing Lys or Orn in positions 12 and 21

Journal of Peptide Science

Volumn 7, Issue 3, 2001, Pages 166-172

  Witkowska, Ewa ^a   Orłowska, Alicja ^a   Sagan, Brunon ^a   Smoluch, Marek ^b   Izdebski, Jan ^a  

^a UNIVERSITY OF WARSAW   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

GH RH; Ornithine analogues; Solid phase peptide synthesis; Tryptic digestion

Indexed keywords

AMINO ACID DERIVATIVE; ARGININE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR AMIDE[1-29][12,21 ORNITHINE 27 NORLEUCINE]; GROWTH HORMONE RELEASING FACTOR AMIDE[1-29][27 NORLEUCINE]; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; GROWTH HORMONE RELEASING FACTOR[1-29]; LYSINE; ORNITHINE; PEPTIDE DERIVATIVE; TRYPSIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BODY FLUID; CHEMICAL BOND; CONTROLLED STUDY; DRUG DESIGN; DRUG STABILITY; HORMONE DETERMINATION; HORMONE SYNTHESIS; HYDROLYSIS; MASS SPECTROMETRY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN STABILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GROWTH HORMONE-RELEASING HORMONE; HUMANS; HYDROLYSIS; LYSINE; MOLECULAR SEQUENCE DATA; ORNITHINE; PEPTIDE BIOSYNTHESIS; PEPTIDE FRAGMENTS; PEPTIDES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TIME FACTORS; TRYPSIN;

EID: 0035061805     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.316     Document Type: Article

References (19)

1. Treatment of growth-hormone deficiency with growth-hormone-releasing hormone
2. Growth hormone-releasing hormone: Clinical perspectives
3. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency
4. 2 in children with idiopathic short stature induces a sustained increase in growth velocity
5. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal man and a GH-deficient boy
6. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men
7. GRF analogues and fragments: Correlation between receptor binding, activity and structure
8. Rational design, synthesis, and biological evaluation of novel growth hormone releasing factor analogues
9. 2 terminus
10. Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma
11. Analogs of bovine growth hormon-releasing factor (bGRF) with various combinations of Arg and/or Lys at positions 11/12 and 20/21. Similar solution conformations of analogs do not translate to equally effective bioactivities in vitro
12. Tryptic hydrolysis of dodecapeptides possessing paired basic residues
13. Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone
14. Chronic administration of a new potent agonist of growth hormone-releasing hormone induces compensatory linear growth in growth hormone-deficient rats: Mechanisms of action
15. 2 on linear growth and GH responsiveness in rats
16. Peptide synthesis with the use of N,N'-dicyclopentyl-carbodiimide
17. N-Cyclohexyl-N'-isopropylcarbodiimide: A hybrid that combines the structural features of DCC and DIC
18. The preparation of Merrifield-resins through total esterification with cesium salts